Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

China Leads India on Drug Patents and Academic Drug Research

publication date: Jul 14, 2011
China’s academic and research institutions received 15% of all patents granted worldwide for drug research in 2007-2008. That far outpaced the 2% that India’s institutions were awarded, and it also handily topped the 5% garnered by US academics. In terms of scientific papers, Indian researchers are third in the world, having published 4,642 biopharma papers in the last decade. However, during the same time period, China published 5,720, good for second place, and the US took first place with 13,314. (Data compiled by the Boston Consulting Group.) More details....

This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

Upcoming Events

ChinaBio® Partnering Forum
September 10–11, 2024 | Shanghai, China
Register here

BIO-Europe®
November 4–6, 2024 | Stockholm, Sweden
Save €900 before September 13!
Register here

Biotech Showcase™
January 13–15, 2025 | San Francisco, CA
Save $600 before September 27!
Other Relevant Events

Antibody Engineering & Therapeutics Asia
October 21–23, 2024 | Kyoto, Japan
Save 30% with code CHINABIO30!
Register here